Lynparza (olaparib) - Merck (MSD), AstraZeneca
Lynparza: Newly added patent in Orange Book (Orange Book) - Jun 5, 2020 - Expiry on March 12, 2024 
Patent Lung Cancer • Oncology • Ovarian Cancer
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
 
Jun 5, 2020
 
 
57040a42-5dfe-4466-8ccc-7dcc620eaa5e.jpg